According to iBio's latest financial reports the company has a price-to-book ratio of 108.761.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 1.61 | 440.14% |
2023-12-31 | 0.2987 | 40.52% |
2022-12-31 | 0.2126 | -83.91% |
2021-12-31 | 1.32 | -36.25% |
2020-12-31 | 2.07 | -107.93% |
2019-12-31 | -26.1 | -2139.66% |
2018-12-31 | 1.28 | -51% |
2017-12-31 | 2.61 | 27.37% |
2016-12-31 | 2.05 | -62.65% |
2015-12-31 | 5.50 | 6.65% |
2014-12-31 | 5.15 | 89.89% |
2013-12-31 | 2.71 | -65.94% |
2012-12-31 | 7.97 | -90.94% |
2011-12-31 | 88.0 | 87.56% |
2010-12-31 | 46.9 | 859.77% |
2009-12-31 | 4.89 | 927.82% |
2008-12-31 | 0.4755 |